Whereas, in a study by Nandi et al., 2022 on a cohort of 271 female breast cancer tissues, higher levels of p53 and lower levels of caspase 3 have been reported with advanced stages (stage II/IV) of the disease, while the vice versa is associated with lower stages (stage I/II). The gene discussed is TP53; the disease is breast carcinoma.